Skip to main content
Quest Diagnostics

A MORC2 Variant Associated With Severe Intellectual Disability and Unusual Phenotype

A MORC2 Variant Associated With Severe Intellectual Disability and Unusual Phenotype

Authors: Wilton-Clark H, Kämpjärvi K, Suchowersky O, Jain-Ghai S

Citation: Am J Med Genet A. 2026 Sep 24. doi: 10.1002/ajmg.a.70307. Online ahead of print.

Specialties: Genetics, Neurology

Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics

Related content

Publication
Autosomal Dominant HK1-Related Neurodevelopmental Disorder With Visual Defects and Brain Anomalies (NEDVIBA): An Emerging Mitochondrial Disorder
Publication
Lunapark Deficiency Leads to an Autosomal Recessive Neurodevelopmental Phenotype With a Degenerative Course, Epilepsy and Distinct Brain Anomalies
Publication
Factors That Influence Genetic Counselors' Professional Identity-A Qualitative Study

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.